ArticlePharmaceuticals (Basel, Switzerland)2021

The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer.

Zachary Heinzman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.